Lipocine Inc. (15)

Browse by Contract Category

Contracts

First Amendment to License Agreement, dated October 14, 2021, made by and among Lipocine Inc., and Antares Pharma, Inc (Filed With SEC on May 9, 2022)
Description of Registered Securities (Filed With SEC on March 9, 2022)
Employment Agreement between Krista Fogarty and Lipocine Inc. dated March 7, 2022 (Filed With SEC on March 7, 2022)
Amendment No. 1 to Commercial Manufacturing Services and Supply Agreement between Lipocine Inc. and MW Encap Ltd. dated October 13, 2021 (Filed With SEC on November 10, 2021)
First Amendment to Loan and Security Agreement, dated February 16, 2021, made by and among Lipocine Inc., Lipocine Operating Inc. and Silicon Valley Bank (Filed With SEC on February 18, 2021)
License Agreement, dated October 14, 2021, by and between Lipocine Inc. and Antares Pharma, Inc (Filed With SEC on November 10, 2021)
Underwriting Agreement, dated January 26, 2021, by and between Lipocine Inc. and Raymond James & Associates, Inc (Filed With SEC on January 27, 2021)
Description of Registered Securities (Filed With SEC on March 13, 2020)
Form of Warrant (Filed With SEC on February 26, 2020)
Placement Agency Agreement, dated as of February 25, 2020, by and between Lipocine, Inc. and Roth Capital Partners, LLC (Filed With SEC on February 26, 2020)
Securities Purchase Agreement, dated as of February 25, 2020, by and between Lipocine, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on February 26, 2020)
Form of Pre-Funded Warrant (Filed With SEC on November 14, 2019)
Form of Common Warrant (Filed With SEC on November 14, 2019)
Placement Agency Agreement, dated as of November 14, 2019, by and between Lipocine, Inc. and Roth Capital Partners, LLC (Filed With SEC on November 14, 2019)
Securities Purchase Agreement, dated as of November 14, 2019, by and between Lipocine, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on November 14, 2019)